SalaryGuide
AboutPricingFor Employers

Marketing jobs

4 marketing jobs

Bio-Rad Laboratories logo
8 days ago

Senior Manager, Global Product Marketing

Bio-Rad Laboratories

Irvine, CA (Hybrid)Full time$157K/yr – $216K/yr
Bio-Rad Laboratories logo
2 weeks ago

Senior Program Manager, Global Brand & MarCom

Bio-Rad Laboratories

California, MO (Remote)Full time$88K/yr – $148K/yr
Bio-Rad Laboratories logo
3 weeks ago

Web Content Strategist

Bio-Rad Laboratories

USA (Remote)Full time$88K/yr – $148K/yr
Bio-Rad Laboratories logo
4 months ago

Sr. Program Manager, Brand MarCom

Bio-Rad Laboratories

Hercules, CA (Remote)Full time$108K/yr – $148K/yr

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

4 jobs
Bio-Rad Laboratories logo

Senior Manager, Global Product Marketing

Bio-Rad Laboratories

Irvine, CA (Hybrid)

$157K/yr - $216K/yrIn-houseFull-timeSenior level7+ years exp.
8 days ago
Bio-Rad Laboratories logo

Senior Program Manager, Global Brand & MarCom

Bio-Rad Laboratories

California, MO (Remote)

$88K/yr - $148K/yrIn-houseFull-timeSenior level8+ years exp.
2 weeks ago
Bio-Rad Laboratories logo

Web Content Strategist

Bio-Rad Laboratories

USA (Remote)

$88K/yr - $148K/yrIn-houseFull-timeMid level5+ years exp.
3 weeks ago
Bio-Rad Laboratories logo

Sr. Program Manager, Brand MarCom

Bio-Rad Laboratories

Hercules, CA (Remote)

$108K/yr - $148K/yrIn-houseFull-timeSenior level8+ years exp.
4 months ago
Bio-Rad Laboratories logo
Bio-Rad Laboratories

Senior Manager, Global Product Marketing

Irvine, CA (Hybrid)

$157K/yr – $216K/yrSenior Level7+ years expFull time

Posted 8 days ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Owns end-to-end product lifecycle and on-market growth for assigned products, translating franchise strategy into concrete plans and coordinating with cross-functional teams to drive growth and lifecycle decisions.

  • Leads VOC, market assessments, and KPIs to inform product plans.
  • Partners with Scientific Affairs, Market Access, Regional Marketing, and Supply Chain to execute launches, manage obsolescence, and sustain profitability.

Job Description

Responsibilities

  • The Senior Manager, Global Product Marketing will drive the day-to-day systematic product line growth and lifecycle management of assigned products or segments, launch execution, on-market growth and support, and obsolescence, and serves as the voice of the customer for their scope.
  • The role translates franchise and segment strategy and customer/market insight into clear product-line plans, commercial inputs (market assessment, segmentation, long-range growth projections, franchise growth initiatives and marketing plans, positioning, pricing recommendations, sales enablement content and product communications) that support global product and marketing strategy, working closely with Market Access, Scientific Affairs, Regional Marketing, Commercial teams, and Supply Chain.
  • Franchise growth strategy & initiatives: Contribute to franchise planning and long-range planning for assigned products or segments, develop on-market growth projections, franchise growth initiatives and marketing plans. Translate global strategy by providing guidance and opportunity data to Regions and Commercial.
  • On-Market Lifecycle, Sustaining Prioritization & CAPA: Understand product performance (quality signals, complaints, cost-to-serve, usage, and mix) and recommend sustaining prioritization, including assay obsolescence and migration, contribute to corrective and preventive actions (CAPA), sustaining activities, and phase-in/phase-out and obsolescence decisions in order to protect customer experience and identify opportunities to improve portfolio productivity and profitability over time.
  • Positioning, additional / expanded claims & evidence inputs: Work with Scientific Affairs, Market Access, and Regional Marketing to shape product claims, value propositions, and messaging that reflect clinical evidence and customer language and that clearly position the product within the segment strategy and competitive landscape, informing evidence plans and assay registration priorities and feeding into global and regional marketing materials.
  • Market research & opportunity assessment: Maintain voice-of-customer (VOC), total-available-market (TAM), serviceable-available-market (SAM), payer/clinical trends, relevant technology developments and the evolution of clinical practice/guidelines, and competitive intelligence for assigned products or segments, and synthesize these inputs into market assessments, customer segmentation (including share/Mekko analyses) and competitor strategies that shape segment strategy, product-line roadmaps, growth opportunities (including IVD partnership opportunities), portfolio gaps and rationalization options, and highlight risks across assigned systems, assays, quality controls and informatics.
  • Performance reporting & franchise KPIs: Utilize dashboards to track revenue, mix, margins, adoption for assigned products or segments and other indicators. Provide insights and recommend corrective actions to key stakeholders.

Requirements

  • Bachelor’s degree or equivalent in Marketing. Advanced degree (e.g., MS, MPH, MBA or similar) is desirable.
  • 7 to 10+ years in Diagnostics/Biotech/Med-Devices. Held a sales role and experience within regional marketing. Proven record of LCM of a product portfolio in a matrix environment.
  • Advanced knowledge of marketing methodologies, concepts, practices, and procedures.
  • Able to translate segment and franchise strategy into concrete product-line plans, commercial hypotheses, and measurable objectives for assigned products or segments.
  • Able to collect and interpret voice-of-customer, competitive information, and usage data to inform requirements and positioning.

Preferred

  • Advanced degree (e.g., MS, MPH, MBA or similar) is desirable.

Benefits

  • Benefits: We’re proud to offer a variety of options, including competitive medical plans for you and your family, free HSA funds, a new fertility offering with stipend, group life and disability, paid parental leave, 401k plus profit sharing, an employee stock purchase program, a new upgraded and streamlined mental health platform, extensive learning and development opportunities, education benefits, student debt relief program, pet insurance, wellness challenges and support, paid time off, Employee Resource Groups (ERG’s), and more!
Bio-Rad Laboratories logo

Bio-Rad Laboratories

3.5 Glassdoor

Bio-Rad provides the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. For more than 70 years we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of almost 8,000 employees and a network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together.

Founded in 1952
Hercules, California, USA
9.2K employees (378 in marketing)
www.bio-rad.com
63% recommend to a friend
76% CEO approval

Traffic Signals

Monthly Visitors
677.2K
Monthly Google Ads Budget
$86.3K
Traffic Source Mix
Search
61.5%
Direct
29.8%
Referral
6.1%
Social
1.7%
Paid
0.8%

Headcount Trend

Current headcount: ~9.2K

Marketing Team

Marketing Team Size
305 (3% of company)
Marketing Roles Posted (Last 30 Days)
3

Funding

Total Funding
$1.4B
Last Raise
$200M
Post IPO Debt, 2 years ago

Funding History

  • Feb 2024
    Post IPO Debt • $200M
  • Mar 2022
    Post IPO Debt • $1.2B

Recent News

Is Bio Rad Laboratories Inc. Class B stock expanding market penetration - Weekly Trend Report & Entry Point Strategy Guides
Nov 21, 2025 • newser.com
Why Bio Rad Laboratories Inc. Class stock stays on top picks
Nov 21, 2025 • newser.com
What is the fair value estimate for Bio Rad Laboratories Inc. Class B stock in 2025 - Portfolio Update Summary & Entry Point Strategy Guides
Nov 20, 2025 • newser.com
Is Bio Rad Laboratories Inc. Class B stock supported by free cash flow - M&A Rumor & Long-Term Safe Return Strategies
Nov 19, 2025 • newser.com
What is the fair value estimate for Bio Rad Laboratories Inc. Class B stock in 2025
Nov 19, 2025 • newser.com
How Bio Rad Laboratories Inc. Class stock reacts to new regulations - Weekly Investment Summary & AI Optimized Trade Strategies
Nov 19, 2025 • newser.com
What to expect from Bio Rad Laboratories Inc. in the next 30 days - Earnings Miss & Breakout Confirmation Alerts
Nov 19, 2025 • newser.com
What to expect from Bio Rad Laboratories Inc. in the next 30 days - Stop Loss & Fast Momentum Entry Tips
Nov 19, 2025 • newser.com
Will Bio Rad Laboratories Inc. stock recover after recent drop - Quarterly Market Review & Real-Time Sentiment Analysis
Nov 19, 2025 • newser.com
Bio-Rad Laboratories (BIO) Price Target Increased by 14.15% to 362.10
Nov 17, 2025 • Nasdaq
Bio-Rad Labs A Getting Closer To Key Technical Benchmark
Nov 13, 2025 • Investor's Business Daily
Is Bio-Rad’s Third Quarter Net Loss and Share Buyback Shaping the Investment Case for BIO?
Nov 12, 2025 • simplywall.st
Is Bio-Rad (BIO) Sending a New Signal With Expanded Buybacks and Diagnostic Partnerships?
Nov 10, 2025 • Sahm
Is Bio-Rad (BIO) Sending a New Signal With Expanded Buybacks and Diagnostic Partnerships?
Nov 2, 2025 • simplywall.st
Is Bio-Rad’s Earnings Miss and Biodesix Partnership Redefining the Investment Outlook for BIO?
Nov 2, 2025 • Yahoo Finance
Bio-Rad Edges Past Expectations But Faces Growth Headwinds
Oct 30, 2025 • Finimize
Bio-Rad Laboratories Stock Dips Amid Valuation Concerns
Oct 30, 2025 • TipRanks
Why Bio-Rad Laboratories Stock Slipped by More Than 3% on Thursday
Oct 30, 2025 • The Motley Fool
Bio-Rad's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Falls
Oct 30, 2025 • Yahoo Finance
Bio-Rad Laboratories (BIO): Losses Widen 51% Annually, Undervalued Status Reinforces Turnaround Narrative
Oct 30, 2025 • simplywall.st
Bio-Rad Laboratories Inc (BIO) Q3 Earnings: Revenue Surpasses Es
Oct 29, 2025 • GuruFocus
Bio-Rad Reports Third-Quarter 2025 Financial Results
Oct 29, 2025 • Business Wire
Bio-Rad Reports Q3 2025 Financial Results Amid Challenges
Oct 29, 2025 • TipRanks
Bio-Rad Laboratories (BIO) Q3 Earnings Miss Estimates
Oct 29, 2025 • Yahoo Finance
Bio-Rad Labs B earnings beat by $0.37, revenue topped estimates
Oct 29, 2025 • investing.com
What to Expect from Bio-Rad Laboratories Inc (BIO) Q3 2025 Earni
Oct 28, 2025 • GuruFocus
Will Bio Rad Laboratories Inc. Class stock outperform value peers - Quarterly Investment Review & Weekly Watchlist of Top Performers
Oct 24, 2025 • newser.com
How Bio Rad Laboratories Inc. (BUW) stock reacts to weak economy - Market Movement Recap & Daily Profit Focused Stock Screening
Oct 24, 2025 • newser.com
Is Bio Rad Laboratories Inc. Class B stock a buy before new product rollout - Weekly Market Outlook & Smart Investment Allocation Tips
Oct 24, 2025 • newser.com
Is Bio Rad Laboratories Inc. Class B stock a buy before new product rollout - July 2025 Movers & Breakout Confirmation Trade Signals
Oct 24, 2025 • newser.com
Bio-Rad Laboratories (BIO): Evaluating Valuation After Major Oncology Diagnostics Partnership Expansion with Biodesix
Oct 24, 2025 • Sahm
Bio-Rad’s iQ-Check Enterobacteriaceae Kit validated for detection of Enterobacteriaceae in infant formula and cereals
Oct 24, 2025 • News-Medical
Is Bio Rad Laboratories Inc. (BUWA) stock a top hedge fund pick - Weekly Trade Review & Reliable Trade Execution Plans
Oct 24, 2025 • newser.com
What Makes Bio-Rad Laboratories (BIO) an Investment Bet?
Oct 23, 2025 • Insider Monkey
What Makes Bio-Rad Laboratories (BIO) an Investment Bet?
Oct 23, 2025 • Yahoo Finance
Will Bio Rad Laboratories Inc. outperform the market - 2025 Buyback Activity & Daily Profit Focused Screening
Oct 23, 2025 • newser.com
Can Bio Rad Laboratories Inc. stock sustain revenue growth - 2025 Performance Recap & Community Trade Idea Sharing
Oct 23, 2025 • newser.com
What RSI levels show for Bio Rad Laboratories Inc. Class B stock - Market Growth Summary & Verified Entry Point Signals
Oct 23, 2025 • newser.com
What valuation multiples suggest for Bio Rad Laboratories Inc. stock - 2025 Performance Recap & Step-by-Step Swing Trade Plans
Oct 23, 2025 • newser.com
A Look at Bio-Rad Laboratories’s Valuation Following Expanded Biodesix Partnership in Cancer Diagnostics
Oct 23, 2025 • Yahoo Finance
Biodesix and Bio-Rad expand collaboration for IVD assays development
Oct 23, 2025 • Medical Device Network
How strong is Bio Rad Laboratories Inc. stock balance sheet - Trade Volume Summary & Weekly Stock Breakout Alerts
Oct 23, 2025 • newser.com
Bio-Rad Laboratories (BIO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Oct 22, 2025 • Nasdaq
Bio-Rad Laboratories (BIO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Oct 22, 2025 • Yahoo Finance
Bio-Rad Laboratories (NYSE:BIO) Russell 1000 Index Innovation
Oct 22, 2025 • Kalkine Media
Is Bio Rad Laboratories Inc. (BUWA) stock a top hedge fund pick - 2025 Institutional Moves & Community Consensus Picks
Oct 22, 2025 • newser.com
How to build a custom watchlist for Bio Rad Laboratories Inc. - July 2025 Levels & Technical Entry and Exit Tips
Oct 21, 2025 • newser.com
Is Bio Rad Laboratories Inc. forming a bottoming base - Weekly Trade Analysis & Weekly High Conviction Ideas
Oct 21, 2025 • newser.com
Why global investors buy Bio Rad Laboratories Inc. (BUWA) stock - July 2025 Momentum & Reliable Intraday Trade Plans
Oct 21, 2025 • newser.com
Is Bio Rad Laboratories Inc. a candidate for recovery play - Weekly Investment Summary & Real-Time Market Sentiment Reports
Oct 21, 2025 • newser.com
Bio-Rad iQ-Check Enterobacteriaceae Kit Receives MicroVal Certification
Oct 21, 2025 • Food Safety Magazine
Is Bio Rad Laboratories Inc. stock poised for growth - Product Launch & Daily Profit Maximizing Tips
Oct 21, 2025 • newser.com
Why Bio Rad Laboratories Inc. Class B stock appears on watchlists - Portfolio Update Summary & Smart Investment Allocation Insights
Oct 20, 2025 • newser.com
Why global investors buy Bio Rad Laboratories Inc. (BUWA) stock - Portfolio Value Summary & Consistent Profit Trading Strategies
Oct 20, 2025 • newser.com
Using Bollinger Bands to evaluate Bio Rad Laboratories Inc. - Market Growth Summary & Free High Return Stock Watch Alerts
Oct 20, 2025 • newser.com
Bio-Rad Laboratories (BIO): Evaluating Valuation as Exclusive Gencurix Deal and Growth Moves Renew Investor Interest
Oct 17, 2025 • Sahm
Bio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025
Oct 16, 2025 • Business Wire
Earnings call transcript: Bio-Rad Labs Q2 2025 shows steady growth
Oct 14, 2025 • investing.com
Bio-Rad Extends Partnership with Gencurix Through Strategic Agreement for Droplet Digital PCR IVD Oncology Kits in Europe
Oct 8, 2025 • the-scientist.com
A Look at Bio-Rad Laboratories’s Valuation Following Precision Medicine Push and New ddPCR Platform Launches
Oct 7, 2025 • Sahm
Bio-Rad signs exclusive European distribution deal with Gencurix for oncology testing kits
Oct 6, 2025 • Pharmafile
Bio-Rad Laboratories Mourns Loss of Co-Founder Alice Schwartz
Oct 1, 2025 • The Globe and Mail
Rapid Food Safety Testing Market to Exceed USD 24.37 Billion by 2034, Driven by Rising Health Standards
Sep 25, 2025 • Precedence Research
Bio-Rad Laboratories, Inc. (BIO) Launches New Instruments, Boosts Molecular Testing Reach
Sep 18, 2025 • Yahoo Finance
How and why the Tri-Valley became a great place for life sciences innovation
Sep 16, 2025 • Seattle TechFlash
U.S. Genotyping Market to Surge USD 26.53 Billion by 2034 at 13.72% CAGR
Sep 15, 2025 • Precedence Research
Blood Testing Market to Reach USD 249.7 Billion by 2035, Growing at 8.2% CAGR from USD 104.4 Billion in 2024 | TMR
Sep 12, 2025 • EIN Presswire
Mutation Detection Kits In Genome Editing Market: Future Demand and Top Key Players Analysis | 2029
Sep 12, 2025 • EIN Presswire
Global Liquid Handling Systems Market to Reach USD 6.94 Billion by 2034
Sep 10, 2025 • EIN Presswire
Global Multi-omics Market to Grow at 16% CAGR, Driven by R&D & Precision Medicine by 2030
Sep 4, 2025 • PharmiWeb
Is Bio-Rad Laboratories (BIO) Entering a Period of More Sustained Recovery?
Sep 2, 2025 • Yahoo Finance
Is it Apt to Hold Bio-Rad Stock in Your Portfolio Now?
Sep 1, 2025 • Nasdaq
Immunoassay Market worth $47.7 billion by 2030 with 6.1% CAGR | MarketsandMarkets™.
Sep 1, 2025 • PR Newswire
New Products Posted to GenomeWeb: BGI, Aptamer Group, Bio-Rad, BioEcho Life Sciences
Aug 29, 2025 • GenomeWeb
Taiwan Conventional PCR Market Forecast, Outlook, and Competitive Landscape 2025-2030
Aug 29, 2025 • Research and Markets
Publication of Half-year report 2025
Aug 27, 2025 • News Powered by Cision
Bio-Rad Expands Range of StarBright Dyes to Enhance Panel Design Capabilities for Spectral Flow Cytometry
Aug 26, 2025 • the-scientist.com
Bio-Rad Hosts Webinar on Digital PCR Advancements
Aug 26, 2025 • TipRanks
Bio-Rad’s Management to Participate in Upcoming September 2025 Investor Conferences
Aug 26, 2025 • BioSpace
Transcript : Bio-Rad Laboratories, Inc. - Special Call
Aug 26, 2025 • MarketScreener
Bio-Rad's Management to Participate in Upcoming Investor Conferences
Aug 25, 2025 • Business Wire
Bio-Rad's Management to Participate in Upcoming Investor Conferences
Aug 25, 2025 • Morningstar.com
Life Science Reagents Market to Reach USD 113.4 Billion by 2035, Expanding at 5.7% CAGR from USD 62.3 Billion in 2024
Aug 22, 2025 • EIN Presswire
Rare Cell Isolation Market 2025-2029: Unveiling Growth Developments with the Latest Updates
Aug 22, 2025 • EIN Presswire
Epigenetics Market Size, Growth Trends, Opportunities & Forecast 2025–2035
Aug 21, 2025 • PharmiWeb
Bio-Detectors And Accessories Market Expanding With $42.88 Billion at 15.8% CAGR by 2029
Aug 20, 2025 • EIN Presswire
Rabies Diagnostics Market 2025-2029: Unveiling Growth Developments with the Latest Updates
Aug 18, 2025 • EIN Presswire
Chromatography Resins Market to Reach $4.72 Billion by 2029 with 10.6% CAGR
Aug 14, 2025 • EIN Presswire
Global Antimicrobial Susceptibility Testing Market Set to Surge: Innovations Driving Rapid Growth 2025
Aug 14, 2025 • EIN Presswire
Chromatography systems are projected to grow steadily, reaching nearly US $15.33 Billion by 2030.
Aug 13, 2025 • EIN Presswire
Demand for Global Mass Spectrometry Market Size to Surpass USD 14.49 Billion by 2034, Exhibit a CAGR of 7.70% - Comprehensive Research Report by Zion Market Research
Aug 13, 2025 • Zion Market Research
Virology and Bacteriology Business Analysis Report 2025 | Market to Reach $2.7 Billion by 2030 - Biopharmaceutical Pipeline Diversification Spurs Demand for Dual-Discipline Expertise and Platforms
Aug 12, 2025 • Research and Markets
The Increasing Value Of The Hba1c Testing Device Market By 2035
Aug 11, 2025 • PharmiWeb
Native Protein Purification Market
Aug 11, 2025 • PharmiWeb
Liver Disease Diagnostics Market Is Projected to Reach $62.6 Billion By 2031, Growing at A CAGR of 6.1%
Aug 11, 2025 • EIN Presswire
Laboratory Proficiency Testing Market Generated Opportunities, Future Scope 2025-2032 | LGC Limited, Merck
Aug 8, 2025 • EIN Presswire
Chromatography Reagents Market to Grow at 8% CAGR Driven by Drug Development and Biopharma by 2030
Aug 8, 2025 • PharmiWeb
Metabolomics Market | Increased Demand, Current and Future Trends, CAGR of 12.2% (2030)
Aug 7, 2025 • EIN Presswire
Optical Genome Mapping Market Set to Reach USD 772.7 Million by 2032, Riding High on Genomic Innovations and Research Demand
Aug 7, 2025 • PharmiWeb
Lung Cancer Screening Market to Reach USD 7.44 Billion by 2032, Driven by LDCT Adoption and Growing High-Risk Population – SNS Insider
Aug 6, 2025 • SNS Insider pvt ltd